Literature DB >> 32395160

Retrogeniculate Lesion of the Visual Pathways: Retinal Optical Coherence Tomography Angiography Shows Evidence of Transsynaptic Retrograde Degeneration.

Francesco Pellegrini1, Emanuela Interlandi1, Francesco Pichi2,3, Andrew G Lee4,5,6,7,8,9.   

Abstract

Transsynaptic retrograde degeneration (TSRD) of the visual pathways is the loss of retinal ganglion cells occurring upstream from a posterior visual pathway lesion. We present a case of a 54-year-old woman with an epidermoid cyst at the right temporo-occipital junction, in whom retinal optical coherence tomography angiography showed a reduction of the superficial retinal capillary density consistent with TSRD. While this reduction has been described in chronic optic neuropathies and pregeniculate lesions, to our knowledge, this is the first case report showing how a reduction in the superficial retinal capillary density occurs also for a postgeniculate lesion.
© 2019 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Optical coherence tomography angiography; superficial capillary plexus; transsynaptic retrograde degeneration

Year:  2019        PMID: 32395160      PMCID: PMC7202434          DOI: 10.1080/01658107.2019.1617748

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  9 in total

1.  TRANS-SYNAPTIC RETROGRADE DEGENERATION IN THE VISUAL SYSTEM OF PRIMATES.

Authors:  J M VANBUREN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-10       Impact factor: 10.154

2.  The time course of retrograde trans-synaptic degeneration following occipital lobe damage in humans.

Authors:  Panitha Jindahra; Aviva Petrie; Gordon T Plant
Journal:  Brain       Date:  2012-02-01       Impact factor: 13.501

3.  Retrograde retinal damage after acute optic tract lesion in MS.

Authors:  Iñigo Gabilondo; María Sepúlveda; Santiago Ortiz-Perez; Elena Fraga-Pumar; Elena H Martínez-Lapiscina; Sara Llufriu; Nuria Solá; Albert Saiz; Bernardo Sanchez-Dalmau; Pablo Villoslada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-05-28       Impact factor: 10.154

4.  Optical Coherence Angiographic Demonstration of Retinal Changes From Chronic Optic Neuropathies.

Authors:  John J Chen; Jackson E AbouChehade; Raymond Iezzi; Jacqueline A Leavitt; Randy H Kardon
Journal:  Neuroophthalmology       Date:  2017-01-27

Review 5.  Role of the macular optical coherence tomography scan in neuro-ophthalmology.

Authors:  Randy H Kardon
Journal:  J Neuroophthalmol       Date:  2011-12       Impact factor: 3.042

6.  Direct demonstration of transsynaptic degeneration in the human visual system: a comparison of retrograde and anterograde changes.

Authors:  R M Beatty; A A Sadun; L Smith; J P Vonsattel; E P Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

7.  Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography.

Authors:  Panitha Jindahra; Aviva Petrie; Gordon T Plant
Journal:  Brain       Date:  2009-02-18       Impact factor: 13.501

8.  Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography.

Authors:  Maud Jacob; Gérald Raverot; Emmanuel Jouanneau; Françoise Borson-Chazot; Gilles Perrin; Muriel Rabilloud; Caroline Tilikete; Martine Bernard; Alain Vighetto
Journal:  Am J Ophthalmol       Date:  2008-09-06       Impact factor: 5.258

9.  Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease.

Authors:  Yuyi You; Chitra Joseph; Chenyu Wang; Vivek Gupta; Sidong Liu; Con Yiannikas; Brian E Chua; Nitin Chitranshi; Ting Shen; Yogita Dheer; Alessandro Invernizzi; Robert Borotkanics; Michael Barnett; Stuart L Graham; Alexander Klistorner
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

  9 in total
  1 in total

1.  Monocular Visual Field Defect on Humphrey 24-2 SITA-Fast Testing Later Identified as a Highly Incongruous Homonymous Defect on Humphrey 30-2 SITA-Fast Testing.

Authors:  Caberry W Yu; Jonathan A Micieli
Journal:  Case Rep Ophthalmol       Date:  2021-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.